XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. (Q38236177)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Stuart G Tangye

series ordinal

1

1 reference

31 August 2017

publication date

2 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Immunology

11 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

772-779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085526%20AND%20SRC:MED&resulttype=core&format=json

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Acquired Agammaglobulinemia after a Life-Threatening Illness with Clinical and Laboratory Features of Infectious Mononucleosis in Three Related Male Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

X-linked lymphoproliferative syndromes and related autosomal recessive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

X-linked lymphoproliferative disease: a progressive immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Molecular and cellular pathogenesis of X-linked lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

X-linked lymphoproliferative disease: twenty-five years after the discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Mapping the X-linked lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

SLAM receptors and SAP influence lymphocyte interactions, development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

SLAM family receptors and SAP adaptors in immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

SAP couples Fyn to SLAM immune receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

A novel receptor involved in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

The SLAM-associated protein signaling pathway is required for development of CD4+ T cells selected by homotypic thymocyte interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Natural killer cell deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

A distinct subpopulation of human NK cells restricts B cell transformation by EBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Epstein-Barr virus superinduces a new human b cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Follicular helper CD4 T cells (TFH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

The origins, function, and regulation of T follicular helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

The good, the bad and the ugly - TFH cells in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

SAP-controlled T-B cell interactions underlie germinal centre formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Somatic mosaicism in primary immune deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-0083-7

Fatal infectious mononucleosis in a family

21 January 2018

1 reference

12 December 2020

Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP

1 reference

12 December 2020

Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity.

1 reference

12 December 2020

A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells

1 reference

12 December 2020

Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects

1 reference

12 December 2020

Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome

1 reference

12 December 2020

Carrier detection in typical and atypical X-linked agammaglobulinemia

1 reference

12 December 2020

Immunoregulatory T cells in males vulnerable to Epstein-Barr virus with the X-linked lymphoproliferative syndrome

1 reference

12 December 2020

Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq

1 reference

12 December 2020

Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule

1 reference

12 December 2020

Activated lymphocytes during acute Epstein-Barr virus infection

1 reference

12 December 2020

Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells

1 reference

12 December 2020

SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1

1 reference

12 December 2020

Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.

1 reference

12 December 2020

Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects

1 reference

12 December 2020

Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP)

1 reference

12 December 2020

Deficient Natural Killer Cell Activity in X-Linked Lymphoproliferative Syndrome

1 reference

12 December 2020

X-linked lymphoproliferative syndrome registry report

1 reference

12 December 2020

X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage phi X 174

1 reference

12 December 2020